Literature DB >> 18202218

Iatrogenic Creutzfeldt-Jakob disease 22 years after human growth hormone therapy: clinical and radiological features.

M Furtner, E Gelpi, S Kiechl, M Knoflach, A Zangerl, T Gotwald, J Willeit, H Maier, T Ströbel, U Unterberger, H Budka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18202218     DOI： 10.1136/jnnp.2007.122267

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Adsorption and decontamination of α-synuclein from medically and environmentally-relevant surfaces.

Authors:  Hanh T M Phan; Jason C Bartz; Jacob Ayers; Benoit I Giasson; Mathias Schubert; Keith B Rodenhausen; Negin Kananizadeh; Yusong Li; Shannon L Bartelt-Hunt
Journal:  Colloids Surf B Biointerfaces       Date:  2018-03-09       Impact factor: 5.268

2.  Iatrogenic Creutzfeldt-Jakob disease, final assessment.

Authors:  Paul Brown; Jean-Philippe Brandel; Takeshi Sato; Yosikazu Nakamura; Jan MacKenzie; Robert G Will; Anna Ladogana; Maurizio Pocchiari; Ellen W Leschek; Lawrence B Schonberger
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

3.  Iatrogenic Creutzfeldt-Jakob disease from commercial cadaveric human growth hormone.

Authors:  Brian S Appleby; Mei Lu; Alberto Bizzi; Michael D Phillips; Sally M Berri; Madeleine D Harbison; Lawrence B Schonberger
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883

Review 4.  The Role of Vesicle Trafficking Defects in the Pathogenesis of Prion and Prion-Like Disorders.

Authors:  Pearl Cherry; Sabine Gilch
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.